Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 603 for hematology

Edit search filters
  1. Epcoritamab Compared To Observation For Treating B-cell Lymphoma Patients Not In Complete Remission After CD19-directed CAR-T Therapy

    Jacksonville, FL, Rochester, MN

  2. A Study Of Caplacizumab In Patients With Acquired Thrombotic Thrombocytopenic Purpura

    Rochester, MN

  3. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab Monotherapy In Participants With Select B-Cell Malignancies (MorningSun)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Group Curriculum For Improving Survivorship Outcomes In Adolescent And Young Adult Cancer Survivors

    Scottsdale/Phoenix, AZ

  5. A Study To Assess Adverse Events Of Intravenously (IV) Infused ABBV-383 In Adult Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Study To Evaluate The Safety And Efficacy Of Magrolimab In Combination With Azacitidine Versus Physician's Choice Of Venetoclax In Combination With Azacitidine Or Intensive Chemotherapy In Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate EAA181 To Treat Newly-diagnosed Multiple Myeloma

    La Crosse, WI, Rochester, MN

  8. A Study To Assess The Safety And Pharmacokinetics Of GDC-8264 In Combination With Standard Of Care In Participants With Acute Graft-Versus-Host Disease (AGVHD)

    Rochester, MN

  9. Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma

    Rochester, MN

  10. A Study To Compare Three Chemotherapy Regimens For The Treatment Of Patients With Newly- Diagnosed Mantle Cell Lymphoma

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer